4 free views remaining today
Lynch syndrome 1
Description
What is Lynch Syndrome?
Lynch syndrome, also known as hereditary non-polyposis colorectal cancer (HNPCC), is a genetic condition that increases the risk of many types of cancers, especially early colorectal cancer [2]. It is an inherited disorder that makes some people more likely to develop certain cancers, often at a younger age in life [6].
Key Features:
- Lynch syndrome is a genetic condition that leads to several types of cancers [3].
- It is passed from parents to children and increases the risk of many kinds of cancer [1].
- The condition is associated with an increased risk of early colorectal cancer, as well as other types of cancers such as ovarian, endometrial, and stomach cancer [7].
Symptoms:
While Lynch syndrome does not have specific symptoms, people with this condition may experience some common signs, including: * Bloody stool * Unexplained diarrhea * A long period of constipation * Abdominal cramps * Decrease in size or caliber of stool * Gas pain [4]
Important Note:
It's essential to note that Lynch syndrome is a genetic condition, and if you have a family history of this condition, it's crucial to consult with a healthcare professional for proper evaluation and guidance.
References: [1] Mar 8, 2024 — Overview [2] Apr 15, 2021 — Lynch syndrome, often called hereditary nonpolyposis colorectal cancer (HNPCC), is an inherited disorder that increases the risk of many types of cancer. [3] Lynch syndrome is a genetic condition that leads to several types of cancers, especially early colorectal cancer. [4] Lynch Syndrome Symptoms · Bloody stool · Unexplained diarrhea · A long period of constipation · Abdominal cramps · Decrease in size or caliber of stool · Gas pain, ... [6] Lynch syndrome is an inherited genetic disorder linked to an increased risk of developing cancer, often at a younger age in life. [7] May 13, 2024 — Lynch syndrome, also called hereditary non-polyposis colorectal cancer (HNPCC), is the most commonly inherited cancer syndrome that increases a person's risk ...
Additional Characteristics
- stomach cancer
- genetic condition
- Lynch syndrome
- hereditary non-polyposis colorectal cancer (HNPCC)
- increases the risk of many types of cancers
- early colorectal cancer
- ovarian cancer
- endometrial cancer
Signs and Symptoms
Common Signs and Symptoms of Lynch Syndrome
Lynch syndrome, also known as hereditary nonpolyposis colorectal cancer (HNPCC), is a genetic condition that increases the risk of developing certain types of cancers. While it's not a disease itself, but rather a trait carried in genes, people with Lynch syndrome may experience various signs and symptoms.
Early Warning Signs
- Colon Cancer: One of the most common signs of Lynch syndrome is colon cancer, especially when diagnosed at a young age (before 45) [8].
- Family History: A family history of colon cancer or other cancers associated with Lynch syndrome can be an indicator of the condition [8].
Other Possible Symptoms
- Abdominal Pain: Stomach pain and discomfort are common symptoms in people with Lynch syndrome [3, 4].
- Fatigue: Unintentional weight loss and fatigue can also occur due to cancer or other related conditions [4, 7].
- Bleeding Inside the Gut: Internal bleeding and reduced ability to absorb nutrients may be experienced by individuals with Lynch syndrome [4].
Important Notes
- No Visible Symptoms: Lynch syndrome itself has no visible symptoms. It's a genetic trait that increases the risk of cancer development.
- General Cancer Symptoms: As cancer progresses, general symptoms like weight loss and anemia can arise, along with symptoms specific to the type of cancer [7].
References: [3] - Context 3 [4] - Context 4 [7] - Context 7 [8] - Context 8
Additional Symptoms
- Colon Cancer
- Family History of colon cancer or other cancers associated with Lynch syndrome
- bleeding
- weight loss
- abdominal pain
- fatigue
Diagnostic Tests
Diagnostic Tests for Lynch Syndrome
Lynch syndrome, also known as Hereditary Nonpolyposis Colorectal Cancer (HNPCC), is a genetic disorder that increases the risk of developing certain types of cancer. Diagnosing Lynch syndrome involves several tests to confirm the presence of the condition.
- Genetic Testing: This is the primary method for diagnosing Lynch syndrome. Genetic testing looks for inherited genetic changes (mutations) in the genes responsible for the condition, such as MLH1, MSH2, MSH6, and PMS2 [2]. A genetic counselor can recommend the best tests to determine if you have a mutation in one of these genes.
- Immunohistochemistry: This test is used to screen for Lynch syndrome tumors by looking for proteins expressed by the major mismatch repair (MMR) genes. If the genes are mutated, the proteins will not be present [4].
- Microsatellite Instability (MSI): MSI is a test that looks for genetic instability in tumor cells. If MSI is found, it may indicate Lynch syndrome, and further testing will be recommended to confirm the diagnosis [6].
Other Tests
In addition to these tests, other diagnostic methods may be used to diagnose cancers associated with Lynch syndrome, such as:
- Colonoscopy: A colonoscopy examines the inside of your large intestine, colon, and rectum with a flexible tube equipped with a camera and light. This test can help identify polyps or cancer in the colon [9].
References
[1] Mar 8, 2024 — Diagnosing Lynch syndrome might start with a review of your family history of cancer.
[2] Oct 16, 2024 — Genetic testing looks for inherited genetic changes (mutations) that cause Lynch syndrome.
[3] There are two methods to perform genetic testing in families with suspected HNPCC, also known as Lynch syndrome or Cancer Family Syndrome.
[4] Immunohistochemistry is a screening test for Lynch syndrome tumors that looks for the proteins expressed by the major mismatch repair (MMR) genes.
[5] Lynch syndrome is diagnosed through genetic testing or tumor screening.
[6] Jan 29, 2024 — If MSI is found, the doctor typically will recommend that the patient be tested for Lynch syndrome-associated gene mutations.
[7] by MB Yurgelun · Cited by 136 — Currently, there are two general approaches to the diagnosis of Lynch syndrome: (1) molecular screening of colorectal and endometrial tumor specimens for ...
[8] This test is used to diagnose or confirm a diagnosis of Lynch syndrome and to assess risk of Lynch syndrome-related malignancies.
[9] What tests diagnose cancers associated with Lynch syndrome? · Colonoscopy: A colonoscopy examines the inside of your large intestine, colon and rectum with a ...
Additional Diagnostic Tests
- Immunohistochemistry
- Genetic Testing
- Colonoscopy
- Microsatellite Instability (MSI)
Treatment
Treatment Options for Lynch Syndrome
Lynch syndrome, also known as hereditary nonpolyposis colorectal cancer (HNPCC), is a genetic disorder that increases the risk of developing certain types of cancer, including colorectal, endometrial, ovarian, and other cancers. The goal of treating Lynch syndrome is to remove the polyps and any presence of cancer.
- Surgical Treatment: Sometimes, an endoscopic approach is sufficient; other times, surgical removal of the affected tissue may be necessary [5].
- Chemotherapy: This uses medication to damage and destroy cancer cells [7].
- Immunotherapy: Immunotherapy drugs called checkpoint inhibitors may prevent serious tumors from forming in some people with an increased risk of cancer due to Lynch syndrome [3].
Specific Treatments
- Jemperli (dostarlimab): May be used to treat MSI-H or dMMR advanced colorectal cancer in people whose cancer got worse after chemotherapy [4].
- Keytruda (pembrolizumab): Is approved for the treatment of any solid tumors that test MSI-H, have progressed after treatment and for which there are no satisfactory alternative treatments [9].
References
[3] Oct 16, 2023 — Immun
Recommended Medications
- Chemotherapy
- Immunotherapy
- Surgical Treatment
- Jemperli (dostarlimab)
- Keytruda (pembrolizumab)
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Understanding Differential Diagnosis in Lynch Syndrome
Differential diagnosis refers to the process of ruling out other possible conditions that may present with similar symptoms or characteristics, in order to arrive at a definitive diagnosis. In the context of Lynch syndrome, differential diagnosis is crucial for identifying and excluding other genetic syndromes that may share similar clinical features.
Conditions to Consider in Differential Diagnosis
According to various medical sources [4, 5, 9], the following conditions should be considered in the differential diagnosis of Lynch syndrome:
- Basal cell naevus syndrome
- Birt–Hogg–Dubé syndrome
- Cowden disease
- Tuberous sclerosis
These conditions may present with similar clinical features to Lynch syndrome, such as an increased risk of certain cancers. However, each of these conditions has distinct genetic and clinical characteristics that can help differentiate them from Lynch syndrome.
Genetic Testing for Differential Diagnosis
In some cases, genetic testing may be necessary to rule out other genetic syndromes that may be part of the differential diagnosis [7]. For example, testing for BRAF variants or MLH1 promoter methylation may be considered medically necessary to exclude a diagnosis of Lynch syndrome.
Importance of Accurate Differential Diagnosis
Accurate differential diagnosis is essential in Lynch syndrome because it can have significant implications for patients and their families. A correct diagnosis can inform treatment decisions, cancer screening recommendations, and genetic counseling [11]. On the other hand, misdiagnosis or failure to consider alternative diagnoses can lead to inappropriate treatment and delayed diagnosis.
References:
[4] - Context result 4 [5] - Context result 9 [7] - Context result 7 [9] - Context result 9 [11] - Context result 11
Additional Differential Diagnoses
- Muir-Torre syndrome
- familial adenomatous polyposis 4
- Basal cell naevus syndrome
- Cowden disease
- N syndrome
- tuberous sclerosis 1
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_2143
- owl#annotatedSource
- t349500
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0070271
- core#notation
- DOID:0070271
- oboInOwl#hasDbXref
- UMLS_CUI:C2936783
- core#exactMatch
- UMLS_CUI:C2936783
- IAO_0000115
- A Lynch syndrome that has_material_basis_in heterozygous mutations in the MSH2 gene on chromosome 2p21-p16.
- oboInOwl#hasExactSynonym
- HNPCC1
- rdf-schema#label
- Lynch syndrome 1
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#NCIthesaurus
- rdf-schema#subClassOf
- t349287
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000147
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.